PR Metex 16 Update on L-Methionine program 04 01 2016



METabolic EXplorer: Update on the L-Methionine program


Clermont-Ferrand, 4 January 2016 - METabolic EXplorer, a biological chemistry company that specialises in developing manufacturing bioprocesses for bio-based compounds used in a wide range of everyday products, including textile fibres, animal feed supplements and resins, makes an update about the L-Methionine program progress.


METabolic EXplorer confirms that good progress is being made in talks with several manufacturers to conclude non-exclusive agreements for the production of 100% bio-based L-Methionine. Letters of intent have already been signed with several parties, and nothing at this stage weakens its confidence in the successful commercialization of this technology. However, the negotiations involved in addressing the manufacturing issues at this level in order to transform these letters of intent into binding agreements with international groups are understandably long. METabolic EXplorer remains confident of a positive outcome in at least one of these negotiations.


-ENDS-


About METabolic EXplorer - www.metabolic-explorer.com

METabolic EXplorer is a biological chemistry company which was incorporated in 1999. Its goal is to help industrial businesses deal with the rise in oil prices, so that they can continue their production, in a different, sustainable way.


Based on the tried and tested principle of industrial fermentation, METabolic EXplorer's solutions replace today's petrochemical processes with the use of a wide range of plant-based raw materials. By optimizing the metabolic yield of non-pathogenic bacteria in a contained, controlled environment, the company facilitates the production of chemical compounds used in a wide range of everyday goods (textile fibres, plastics, resins, solvents or animal feed supplements).


METabolic EXplorer is currently focusing its alternative processes on the production of three compounds that together have an estimated, annual, end-market value of €7 billion. The company's strategy will be implemented through industrial partnerships in the shape of licenses and joint ventures, as well as own-account production units.


METabolic EXplorer, based in Clermont-Ferrand, France, is listed on Euronext in Paris (Compartment C, METEX) and is part of the CAC Small index and EnterNext Tech40 label.


Get free financial information on METabolic EXplorer by registering with: www.metabolic-explorer.com or www.actus-finance.com

Media and individual shareholder relations


ATTITUDE Corporate

Eric de Lambert

E-mail: edelambert@attitude-corporate.com Tél.: +33 (0)1 4970 4341 / +33 (0)6 2529 0658


Investor and analyst relations ACTUS Finance et Communication

Jérôme Fabreguettes-Leib E-mail: jfl@actus.fr

Tel: +33 (0)1 5367 3678


This communication includes forward-looking information which is subject to risks and uncertainties. The potential development of the company could be substantially different from that anticipated in this press release because of the various risk factors which are described in the company's Listing Prospectus.

Metabolic Explorer SA issued this content on 2016-01-04 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-04 18:02:08 UTC

Original Document: http://www.metabolic-explorer.com/images/dynmetex/biblio/fichiers/CP_METEX_2016/PR_Metex_16_Update_on_L_Methionine_program_04_01_2016.pdf